Literature DB >> 9795995

Detection of microorganisms in vessel wall specimens of the abdominal aorta: development of a PCR assay in the absence of a gold standard.

A Meijer1, J A van der Vliet, L M Schouls, A de Vries, P J Roholl, J M Ossewaarde.   

Abstract

A procedure in which the "Invitrogen Easy-DNA" kit was followed by a silica-based method for the isolation of DNA was developed for extraction of PCR-inhibitor-free DNA from up to 300 mg of human vessel wall tissue. Optimally designed PCR assays were developed for the detection of at least one infected cell in this amount of tissue. Details of the procedure are given for the detection of DNA of Chlamydia pneumoniae, cytomegalovirus and herpes simplex virus type 1 and type 2 in human vessel walls. The procedure can serve as a reference method or as a gold standard when a high-performance method is needed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795995     DOI: 10.1016/s0923-2508(99)80005-9

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  10 in total

Review 1.  Molecular diagnosis of Chlamydia pneumoniae infection.

Authors:  J Boman; C A Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens.

Authors:  P Apfalter; F Blasi; J Boman; C A Gaydos; M Kundi; M Maass; A Makristathis; A Meijer; R Nadrchal; K Persson; M L Rotter; C Y Tong; G Stanek; A M Hirschl
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

3.  Molecular evidence for association of chlamydiales bacteria with epitheliocystis in leafy seadragon (Phycodurus eques), silver perch (Bidyanus bidyanus), and barramundi (Lates calcarifer).

Authors:  Adam Meijer; Paul J M Roholl; Jacobus M Ossewaarde; Brian Jones; Barbara F Nowak
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

4.  Diagnosing genital ulcer disease in a clinic for sexually transmitted diseases in Amsterdam, The Netherlands.

Authors:  S M Bruisten; I Cairo; H Fennema; A Pijl; M Buimer; P G Peerbooms; E Van Dyck ; A Meijer; J M Ossewaarde; G J van Doornum
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain.

Authors:  R H Ring; J M Lyons
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

6.  Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions.

Authors:  A Meijer; P J Roholl; S K Gielis-Proper; J M Ossewaarde
Journal:  J Clin Pathol       Date:  2000-12       Impact factor: 3.411

7.  Practical implementation of a multiplex PCR for acute respiratory tract infections in children.

Authors:  Paul Gruteke; Afina S Glas; Mirjam Dierdorp; Willem B Vreede; Jan-Willem Pilon; Sylvia M Bruisten
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

8.  PCR assessment of Chlamydia trachomatis infection of semen specimens processed for artificial insemination.

Authors:  Y Pannekoek; S M Westenberg; J de Vries; S Repping; L Spanjaard; P P Eijk; A van der Ende; J Dankert
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

9.  Community-acquired pathogens associated with prolonged coughing in children: a prospective cohort study.

Authors:  F G A Versteegh; G J Weverling; M F Peeters; B Wilbrink; M T M Veenstra-van Schie; J M van Leeuwen-Gerritsen; E A N M Mooi-Kokenberg; J F P Schellekens; J J Roord
Journal:  Clin Microbiol Infect       Date:  2005-10       Impact factor: 8.067

10.  Evaluation of five DNA extraction methods for purification of DNA from atherosclerotic tissue and estimation of prevalence of Chlamydia pneumoniae in tissue from a Danish population undergoing vascular repair.

Authors:  Tina Mygind; Lars Østergaard; Svend Birkelund; Jes S Lindholt; Gunna Christiansen
Journal:  BMC Microbiol       Date:  2003-09-02       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.